| Dr Jeffrey Paul Allerton, MD | |
|
1 Atwell Rd, Cooperstown, NY 13326-1301 | |
| (607) 547-3336 | |
| (607) 547-3891 |
| Full Name | Dr Jeffrey Paul Allerton |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 38 Years |
| Location | 1 Atwell Rd, Cooperstown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205886181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 239959 (New York) | Primary |
| 207RH0002X | Internal Medicine - Hospice And Palliative Medicine | 239959 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bassett Healthcare | Cooperstown, NY | Hospital |
| Aurelia Osborn Fox Memorial Hospital | Oneonta, NY | Hospital |
| Cobleskill Regional Hospital | Cobleskill, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bassett Healthcare | 3779488325 | 641 |
News Archive
MEDecision, Inc., a leading provider of collaborative health care management solutions, today announced that it will deliver its Alineo® collaborative health care management platform and Nexalign® collaborative health care information exchange service to the Arkansas Foundation for Medical Care (AFMC).
Haemonetics Corporation announced today that on May 28, 2010, the United States Patent and Trademark Office issued a decision confirming the validity of Haemonetics' '983 Patent in light of numerous prior art references cited by Fenwal Inc. As such, the USPTO explicitly rejected Fenwal's position that the Patent was invalid over the prior art.
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study.
Teva Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York has set a trial date of September 7, 2011 in the Company's ongoing patent infringement litigation against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Pharmaceuticals, Inc./Mylan Inc./Natco Pharma Ltd. regarding their purported generic versions of COPAXONE® (glatiramer acetate injection).
Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.
› Verified 9 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20031205000553 |
News Archive
MEDecision, Inc., a leading provider of collaborative health care management solutions, today announced that it will deliver its Alineo® collaborative health care management platform and Nexalign® collaborative health care information exchange service to the Arkansas Foundation for Medical Care (AFMC).
Haemonetics Corporation announced today that on May 28, 2010, the United States Patent and Trademark Office issued a decision confirming the validity of Haemonetics' '983 Patent in light of numerous prior art references cited by Fenwal Inc. As such, the USPTO explicitly rejected Fenwal's position that the Patent was invalid over the prior art.
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study.
Teva Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York has set a trial date of September 7, 2011 in the Company's ongoing patent infringement litigation against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Pharmaceuticals, Inc./Mylan Inc./Natco Pharma Ltd. regarding their purported generic versions of COPAXONE® (glatiramer acetate injection).
Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.
› Verified 9 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
MEDecision, Inc., a leading provider of collaborative health care management solutions, today announced that it will deliver its Alineo® collaborative health care management platform and Nexalign® collaborative health care information exchange service to the Arkansas Foundation for Medical Care (AFMC).
Haemonetics Corporation announced today that on May 28, 2010, the United States Patent and Trademark Office issued a decision confirming the validity of Haemonetics' '983 Patent in light of numerous prior art references cited by Fenwal Inc. As such, the USPTO explicitly rejected Fenwal's position that the Patent was invalid over the prior art.
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study.
Teva Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York has set a trial date of September 7, 2011 in the Company's ongoing patent infringement litigation against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Pharmaceuticals, Inc./Mylan Inc./Natco Pharma Ltd. regarding their purported generic versions of COPAXONE® (glatiramer acetate injection).
Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Paul Allerton, MD 1 Atwell Rd, Cooperstown, NY 13326-1301 Ph: (607) 547-3336 | Dr Jeffrey Paul Allerton, MD 1 Atwell Rd, Cooperstown, NY 13326-1301 Ph: (607) 547-3336 |
News Archive
MEDecision, Inc., a leading provider of collaborative health care management solutions, today announced that it will deliver its Alineo® collaborative health care management platform and Nexalign® collaborative health care information exchange service to the Arkansas Foundation for Medical Care (AFMC).
Haemonetics Corporation announced today that on May 28, 2010, the United States Patent and Trademark Office issued a decision confirming the validity of Haemonetics' '983 Patent in light of numerous prior art references cited by Fenwal Inc. As such, the USPTO explicitly rejected Fenwal's position that the Patent was invalid over the prior art.
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study.
Teva Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York has set a trial date of September 7, 2011 in the Company's ongoing patent infringement litigation against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Pharmaceuticals, Inc./Mylan Inc./Natco Pharma Ltd. regarding their purported generic versions of COPAXONE® (glatiramer acetate injection).
Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.
› Verified 9 days ago
Marguerite Duplessis, PA-C Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3153 Fax: 607-547-6539 | |
Dr. Ann K Eldred, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3350 Fax: 607-547-6989 | |
Dr. Donald A Raddatz, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3284 Fax: 607-547-4648 | |
Abigail Marie Pichel Quintos, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3283 Fax: 607-547-6906 | |
Dr. Jerel M Zoltick, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3181 Fax: 607-547-6857 | |
Dr. Brenda J Davies-wait, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3259 Fax: 607-547-3259 | |
Dr. Eric N Bravin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3336 Fax: 607-547-6541 |